• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后 BK 多瘤病毒和巨细胞病毒合并感染的临床特征。

Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation.

机构信息

Division of General Internal Medicine, Nephrology and Rheumatology, Department of Medicine D, University Hospital of Münster, 48149, Münster, Germany.

Department of Internal Medicine and Nephrology, University Hospital of Münster Marienhospital Steinfurt, 48565, Steinfurt, Germany.

出版信息

Sci Rep. 2020 Dec 29;10(1):22406. doi: 10.1038/s41598-020-79799-6.

DOI:10.1038/s41598-020-79799-6
PMID:33376243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7772341/
Abstract

BK polyomavirus (BKPyV) and cytomegalovirus (CMV) are the main viral pathogens affecting the graft and recipient outcome after allogenic kidney transplantation. It has recently been found that infection with both viruses has a greater impact on kidney graft function than a single infection. We retrospectively analyzed a cohort of 723 recipients who received kidney transplantation between 2007 and 2015 after living and postmortal donation for differences in risk and outcome parameters regarding BKPyV (DNAemia) and CMV (CMV DNAemia) co-infection compared to sole viremias and to patients without viremia. Of all kidney allograft recipients in our cohort, 8.2% developed co-infection with BKPyV DNAemia and CMV DNAemia, 15.1% showed BKPyV viremia alone and 25.2% sole CMV DNAemia. Acute rejection was closely linked with co-infection (multivariable analysis, p = 0.001). Despite the fact that the estimated glomerular filtration rate of patients with co-infection was noticeably reduced compared to patients with BKV or CMV infection alone, transplant survival and patient survival were not significantly reduced. Co-infection with BKPyV and CMV in kidney transplanted patients is significantly associated with inferior allograft function. Since co-infection is strongly associated with acute rejection, co-infected individuals should be considered a risk collective.

摘要

BK 多瘤病毒(BKPyV)和巨细胞病毒(CMV)是影响同种异体肾移植后移植物和受者结局的主要病毒病原体。最近发现,两种病毒的感染对肾脏移植物功能的影响大于单一感染。我们回顾性分析了 723 例于 2007 年至 2015 年期间接受活体和死后供体肾移植的受者,比较 BKPyV(DNAemia)和 CMV(CMV DNAemia)合并感染与单纯病毒血症及无病毒血症患者在风险和结局参数方面的差异。在我们的队列中,所有肾移植受者中,8.2%发生 BKPyV DNAemia 和 CMV DNAemia 合并感染,15.1%出现单纯 BKPyV 病毒血症,25.2%出现单纯 CMV DNAemia。急性排斥反应与合并感染密切相关(多变量分析,p=0.001)。尽管合并感染患者的估算肾小球滤过率明显低于单纯 BKPyV 或 CMV 感染患者,但移植存活率和患者存活率无显著降低。肾移植患者 BKPyV 和 CMV 合并感染与移植物功能受损显著相关。由于合并感染与急性排斥反应密切相关,因此应将合并感染者视为高危人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/5f3b476ea025/41598_2020_79799_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/eda93c9f5cc8/41598_2020_79799_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/10d3fd619f9f/41598_2020_79799_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/1e90b2c10aeb/41598_2020_79799_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/75fe5d2828ca/41598_2020_79799_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/5f3b476ea025/41598_2020_79799_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/eda93c9f5cc8/41598_2020_79799_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/10d3fd619f9f/41598_2020_79799_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/1e90b2c10aeb/41598_2020_79799_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/75fe5d2828ca/41598_2020_79799_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/7772341/5f3b476ea025/41598_2020_79799_Fig5_HTML.jpg

相似文献

1
Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation.肾移植后 BK 多瘤病毒和巨细胞病毒合并感染的临床特征。
Sci Rep. 2020 Dec 29;10(1):22406. doi: 10.1038/s41598-020-79799-6.
2
Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.肾移植受者巨细胞病毒与BK多瘤病毒合并感染性肾病的结局
Saudi J Kidney Dis Transpl. 2018 Jan-Feb;29(1):101-106. doi: 10.4103/1319-2442.225198.
3
Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.肾移植受者在接受显著BK多瘤病毒感染或BK多瘤病毒相关性肾病治疗后的第一年随访期后肾功能的稳定情况。
Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12681. Epub 2017 Apr 17.
4
Concurrent JCPyV-DNAemia Is Correlated With Poor Graft Outcome in Kidney Transplant Recipients With Polyomavirus-associated Nephropathy.巨细胞病毒 -DNA 血症与肾移植受者多瘤病毒相关性肾病的不良移植物结局相关。
Transplantation. 2024 Aug 1;108(8):1802-1811. doi: 10.1097/TP.0000000000004995. Epub 2024 Jul 20.
5
Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.两名接受同一供体同种异体移植物的肾移植患者,由于低中和抗体滴度而发生早期暴发性 BK 多瘤病毒相关性肾病。
Virol J. 2020 Jan 10;17(1):5. doi: 10.1186/s12985-019-1275-9.
6
CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.巨细胞病毒血症与肾和肾胰移植后 BK 病毒再激活的发生率降低有关。
Transplantation. 2013 Dec 27;96(12):1097-103. doi: 10.1097/TP.0b013e3182a6890d.
7
Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.移植前供体-受体对BK多瘤病毒的血清反应性可预测肾移植后的病毒血症和肾病。
Am J Transplant. 2017 Jan;17(1):161-172. doi: 10.1111/ajt.13880. Epub 2016 Jul 8.
8
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.巨细胞病毒预防策略与 BK 多瘤病毒血症和肾病的风险。
Am J Transplant. 2019 Sep;19(9):2457-2467. doi: 10.1111/ajt.15507. Epub 2019 Jul 9.
9
CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?巨细胞病毒感染、缬更昔洛韦暴露与肾移植后 BK 病毒血症及相关肾病的风险:二者是否存在关联?
Transpl Infect Dis. 2021 Aug;23(4):e13597. doi: 10.1111/tid.13597. Epub 2021 Mar 23.
10
BK polyomavirus DNAemia, allograft rejection, and de novo donor-specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients.BK 多瘤病毒血症、同种异体移植排斥反应和目标他克莫司水平降低后在儿科肾移植受者中产生的新型供体特异性抗体。
Pediatr Transplant. 2024 Aug;28(5):e14791. doi: 10.1111/petr.14791.

引用本文的文献

1
Transplant centers' prophylaxis and monitoring strategies: a key determinant of current herpes and polyomavirus incidences - results from the DZIF kidney transplant cohort.移植中心的预防和监测策略:当前疱疹病毒和多瘤病毒发病率的关键决定因素——德国感染研究中心肾移植队列研究结果
BMC Nephrol. 2025 Apr 30;26(1):218. doi: 10.1186/s12882-025-04084-5.
2
The simultaneous presence of active BK, Epstein Barr, and human cytomegalovirus infection and their correlation by host factors in patients suspected of kidney transplant rejection.在疑似肾移植排斥的患者中,同时存在 BK、Epstein Barr 和人巨细胞病毒感染及其与宿主因素的相关性。
BMC Infect Dis. 2024 Sep 9;24(1):937. doi: 10.1186/s12879-024-09821-z.
3

本文引用的文献

1
Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipients.BK 病毒血症的管理与降低肾移植受者后续巨细胞病毒感染的风险相关。
Clin Transplant. 2020 Mar;34(3):e13798. doi: 10.1111/ctr.13798. Epub 2020 Feb 11.
2
Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation.肾移植中活体及尸体供肾后的巨细胞病毒血症
J Clin Med. 2020 Jan 17;9(1):252. doi: 10.3390/jcm9010252.
3
Letter to the Editor concerning "Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy".
Bridging the gap: assessing CMV DNAemia in kidney transplant recipients with previous solid organ transplants.
弥合差距:评估曾接受实体器官移植的肾移植受者的巨细胞病毒血症。
Front Transplant. 2024 Apr 9;3:1280280. doi: 10.3389/frtra.2024.1280280. eCollection 2024.
4
Concomitant Polyoma BK Virus and West Nile Virus in Renal Allografts.肾移植受者中BK多瘤病毒与西尼罗河病毒共感染
Pathogens. 2023 Dec 15;12(12):1456. doi: 10.3390/pathogens12121456.
5
Risk Factors for CMV and BK Infections in an Elderly Veteran Population Following Kidney Transplantation: Implications for Immunosuppression Induction and Management.老年退伍军人肾移植后巨细胞病毒和BK病毒感染的危险因素:对免疫抑制诱导和管理的启示
Biomedicines. 2023 Nov 15;11(11):3060. doi: 10.3390/biomedicines11113060.
6
Spontaneous carotid blowout of the common carotid artery in a chronically immunosuppressed transplant patient.一名长期免疫抑制的移植患者发生颈总动脉自发性颈动脉破裂。
J Vasc Surg Cases Innov Tech. 2022 Oct 18;8(4):715-718. doi: 10.1016/j.jvscit.2022.10.005. eCollection 2022 Dec.
7
Risk Factors for Polyomavirus, Cytomegalovirus, and Viruria Co-Infection for Follow-Up of Renal Transplant Patients.肾移植患者随访中多瘤病毒、巨细胞病毒和病毒尿症合并感染的危险因素。
Ann Transplant. 2022 Oct 25;27:e937771. doi: 10.12659/AOT.937771.
8
The Prevalence of Neurological Complication after Renal Transplantation.肾移植术后神经并发症的患病率
Evid Based Complement Alternat Med. 2022 Jul 4;2022:8763304. doi: 10.1155/2022/8763304. eCollection 2022.
9
BK Virus and Cytomegalovirus Coinfections in Kidney Transplantation and Their Impact on Allograft Loss.肾移植中的BK病毒与巨细胞病毒合并感染及其对移植肾丢失的影响
J Clin Med. 2021 Aug 24;10(17):3779. doi: 10.3390/jcm10173779.
致编辑的信:关于“巨细胞病毒预防策略与BK多瘤病毒血症及肾病风险”
Am J Transplant. 2019 Dec;19(12):3438-3439. doi: 10.1111/ajt.15648. Epub 2019 Nov 6.
4
BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.BK 多瘤病毒特异性抗体和 T 细胞反应在肾移植中的研究进展。
Curr Opin Infect Dis. 2019 Dec;32(6):575-583. doi: 10.1097/QCO.0000000000000602.
5
Valganciclovir is not a risk factor of BK polyomavirus viremia.缬更昔洛韦不是BK多瘤病毒血症的危险因素。
Am J Transplant. 2019 Dec;19(12):3436-3437. doi: 10.1111/ajt.15610. Epub 2019 Oct 16.
6
BK polyomavirus and valganciclovir: Evidence is still lacking.BK多瘤病毒与缬更昔洛韦:仍缺乏证据。
Am J Transplant. 2019 Dec;19(12):3432-3433. doi: 10.1111/ajt.15562. Epub 2019 Sep 9.
7
Prevalence, Risk Factors, Treatment, and Overall Impact of BK Viremia on Kidney Transplantation.BK病毒血症在肾移植中的患病率、危险因素、治疗及总体影响
Transplant Proc. 2019 Jul-Aug;51(6):1801-1809. doi: 10.1016/j.transproceed.2019.03.035.
8
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.巨细胞病毒预防策略与 BK 多瘤病毒血症和肾病的风险。
Am J Transplant. 2019 Sep;19(9):2457-2467. doi: 10.1111/ajt.15507. Epub 2019 Jul 9.
9
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.一项开放性、随机试验表明,依维莫司联合他克莫司或环孢素与标准免疫抑制方案在肾移植初治患者中的疗效相当。
Kidney Int. 2019 Jul;96(1):231-244. doi: 10.1016/j.kint.2019.01.041. Epub 2019 Feb 27.
10
BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.BK 多瘤病毒在实体器官移植中的作用——美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13528. doi: 10.1111/ctr.13528. Epub 2019 Apr 10.